Evidence map›Paper›PMID 40977767›Full record

ArticleFrontiers in public health2025

Size-dependent retention of elongate mineral particles in human lungs: modeling and implications for risk assessment.

Andrey Korchevskiy, Richard Attanoos, Ann G Wylie

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrey KorchevskiyChemistry and Industrial Hygiene, Inc., Lakewood, CO, United States.
Richard AttanoosDepartment of Cellular Pathology, University Hospital of Wales & School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.
Ann G WylieDepartment of Geology, University of Maryland, College Park, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lung deposition of elongate amphibole particles is an important process impacting the risk of cancer. There is, however, a significant gap in scientific literature characterizing the role of particle size in the differences observed for deposition and clearance rate in the human respiratory system. The purpose of the paper is to explore the relationship between size distribution of elongate mineral particles in human lungs compared to corresponding distribution in the airborne exposure. Materials and methods: Previously published information about lung deposition for amosite and crocidolite particles in various dimensional groups, collected by the team of Pooley and Clark was reanalyzed with application of recently developed methodologies for fiber size analysis. The new metric-deposition selection ratio (DSR) is proposed; it is found by dividing the size fraction of particles in lungs to the corresponding fraction in exposure. The DSR estimations were also compared to theoretical estimations of pulmonary deposition rates of particles based on the United States Environmental Protection Agency (US EPA) Multi-Path Particle Dosimetry (MPPD) model. Results: It was demonstrated that DSR values can be approximated by using log-log regressions with length and width of particles as independent variables. For non-asbestiform particles (cleavage fragments), the prediction of DSR from parametric and non-parametric models is demonstrated to be less than 1 (evidence of deselection in lungs). Negative correlation was found for DSR estimations and the theoretical predictions of pulmonary deposition rates by MPPD. Discussion: The observed data for size-specific lung deposition of elongate mineral particles can be used for quantitative estimates of risk and analysis of toxicokinetic processes in human lungs. The difference between theoretical model and observed fiber deposition pattern requires further adjustments in the methods to predict lung deposition of elongate particles.

Indexed as

Air PollutantsAsbestos, AmphiboleInhalation ExposureLungParticle SizeHumansRisk AssessmentUnited StatesAir PollutantsAsbestos, Amphiboleasbestosfiber lengthfiber widthlung depositionnon-asbestiform particles

Identifiers

PMID40977767
PMCPMC12443763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.